727 related articles for article (PubMed ID: 19926618)
1. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ
Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
[TBL] [Abstract][Full Text] [Related]
2. IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer.
Li Y; Deuring J; Peppelenbosch MP; Kuipers EJ; de Haar C; van der Woude CJ
Carcinogenesis; 2012 Oct; 33(10):1889-96. PubMed ID: 22739025
[TBL] [Abstract][Full Text] [Related]
3. Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis.
Yu LZ; Wang HY; Yang SP; Yuan ZP; Xu FY; Sun C; Shi RH
World J Gastroenterol; 2013 May; 19(17):2638-49. PubMed ID: 23674871
[TBL] [Abstract][Full Text] [Related]
4. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission.
Xu AT; Li Y; Zhao D; Shen J; Xu XT; Qiao YQ; Zhu MM; Wang TR; Cui Y; Ai LY; Ran ZH
Inflamm Bowel Dis; 2015 Feb; 21(2):241-50. PubMed ID: 25545374
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of IL6/IL6R-STAT3-SOCS3 signaling pathway in IBD-associated colorectal dysplastic lesions as compared to sporadic colorectal adenomas in non-IBD patients.
Gui X; Iacucci M; Ghosh S
Pathol Res Pract; 2020 Nov; 216(11):153211. PubMed ID: 32979687
[TBL] [Abstract][Full Text] [Related]
6. Qing Hua Chang Yin inhibits the LPS-induced activation of the IL-6/STAT3 signaling pathway in human intestinal Caco-2 cells.
Ke X; Hu G; Fang W; Chen J; Zhang X; Yang C; Peng J; Chen Y; Sferra TJ
Int J Mol Med; 2015 Apr; 35(4):1133-7. PubMed ID: 25633437
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.
Polytarchou C; Hommes DW; Palumbo T; Hatziapostolou M; Koutsioumpa M; Koukos G; van der Meulen-de Jong AE; Oikonomopoulos A; van Deen WK; Vorvis C; Serebrennikova OB; Birli E; Choi J; Chang L; Anton PA; Tsichlis PN; Pothoulakis C; Verspaget HW; Iliopoulos D
Gastroenterology; 2015 Oct; 149(4):981-92.e11. PubMed ID: 26055138
[TBL] [Abstract][Full Text] [Related]
8. Increased suppressor of cytokine signaling-3 expression predicts mucosal relapse in ulcerative colitis.
Li Y; Nuij VJ; Baars JE; Biermann K; Kuipers EJ; Peppelenbosch MP; de Haar C; Janneke van der Woude C
Inflamm Bowel Dis; 2013 Jan; 19(1):132-40. PubMed ID: 22535619
[TBL] [Abstract][Full Text] [Related]
9. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
[TBL] [Abstract][Full Text] [Related]
10. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
[TBL] [Abstract][Full Text] [Related]
11. IL-6/STAT3/SOCS3 signaling pathway playing a regulatory role in ulcerative colitis carcinogenesis.
Chen YY; Ma ZB; Xu HY; Shi LJ; Li DY; Sun LY; Yin XH; Sang GY; Xu D; Tang YH; Wang X; Li P; Wu F; Zhou J
Int J Clin Exp Med; 2015; 8(8):12009-17. PubMed ID: 26550113
[TBL] [Abstract][Full Text] [Related]
12. STAT1, STAT6 and adenosine 3',5'-cyclic monophosphate (cAMP) signaling drive SOCS3 expression in inactive ulcerative colitis.
Li Y; Deuring J; Peppelenbosch MP; Kuipers EJ; de Haar C; van der Woude CJ
Mol Med; 2012 Dec; 18(1):1412-9. PubMed ID: 23154639
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of mucosal suppressors of cytokine signaling 3 expression in ulcerative colitis.
Miyanaka Y; Ueno Y; Tanaka S; Yoshioka K; Hatakeyama T; Shimamoto M; Sumii M; Chayama K
World J Gastroenterol; 2007 Jun; 13(21):2939-44. PubMed ID: 17589943
[TBL] [Abstract][Full Text] [Related]
14. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer.
Chen R; Pan S; Lai K; Lai LA; Crispin DA; Bronner MP; Brentnall TA
World J Gastroenterol; 2014 Dec; 20(45):17037-48. PubMed ID: 25493016
[TBL] [Abstract][Full Text] [Related]
16. IL-9 promotes the pathogenesis of ulcerative colitis through STAT3/SOCS3 signaling.
Tian L; Li Y; Zhang J; Chang R; Li J; Huo L
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30369485
[TBL] [Abstract][Full Text] [Related]
17. Shift from pStat6 to pStat3 predominance is associated with inflammatory bowel disease-associated dysplasia.
Wick EC; LeBlanc RE; Ortega G; Robinson C; Platz E; Pardoll DM; Iacobuzio-Donahue C; Sears CL
Inflamm Bowel Dis; 2012 Jul; 18(7):1267-74. PubMed ID: 22021169
[TBL] [Abstract][Full Text] [Related]
18. Pien Tze Huang ameliorates DSS‑induced colonic inflammation in a mouse colitis model through inhibition of the IL‑6/STAT3 pathway.
Li L; Shen A; Chu J; Sferra TJ; Sankararaman S; Ke X; Chen Y; Peng J
Mol Med Rep; 2018 Jul; 18(1):1113-1119. PubMed ID: 29845215
[TBL] [Abstract][Full Text] [Related]
19. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
[TBL] [Abstract][Full Text] [Related]
20. EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients.
Srivatsa S; Paul MC; Cardone C; Holcmann M; Amberg N; Pathria P; Diamanti MA; Linder M; Timelthaler G; Dienes HP; Kenner L; Wrba F; Prager GW; Rose-John S; Eferl R; Liguori G; Botti G; Martinelli E; Greten FR; Ciardiello F; Sibilia M
Gastroenterology; 2017 Jul; 153(1):178-190.e10. PubMed ID: 28400195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
